Relaxin
Relaxin is an insulin-family peptide hormone that remodels connective tissue by increasing collagenase activity while inhibiting fibrosis. It shows strong anti-fibrotic effects in the heart, kidneys, and lungs.
Protocol
25–400 mcg/kg IV or subcutaneous in clinical trials
Half-Life
10–15 minutes
Molecular Structure & Chemistry
10 residues • 142 atoms • Skeletal Formula
C41H72N12O17
824.93 g/mol
1004.515 Da
6.01
0
+0.25
Amino Acid Sequence
Biological Mechanisms
Anti-fibrotic
Observed in clinical research as a primary mechanism of action for Relaxin.
Connective tissue remodeling
Observed in clinical research as a primary mechanism of action for Relaxin.
Vasodilation
Observed in clinical research as a primary mechanism of action for Relaxin.
Cardiac protection
Observed in clinical research as a primary mechanism of action for Relaxin.
Lung fibrosis treatment potential
Observed in clinical research as a primary mechanism of action for Relaxin.
Safety & Risk Analysis
Critical Safety Warning
Black market peptides can be contaminated, mislabeled, or dangerous. Only obtain peptides via a registered doctor and legitimate pharmacy. Never attempt self-administration without professional medical supervision.
Community Journey Log
Log Your Journey
Share your research observations with the community.
Sign in to contribute
Create a free account to log your research journey and share observations with the community.
Community Observations (0)
No journey logs yet. Be the first to share.
Quick Reference
This compound is for research purposes only. Clinical applications must be directed by a licensed physician.
View Community Logs